David J Gracie (D J Gracie)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 11

Top Venues

Alimentary pharmacology & therapeutics

Gut

Therapeutic advances in gastroenterology

Leeds Teaching Hospitals NHS Trust

University of Leeds (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Leeds Teaching Hospitals NHS Trust

United Kingdom

Consultant :: Gastroenterology

Education History

University of Leeds

United Kingdom

PHD

University of St Andrews

United Kingdom

BSC

Publications

Christy Riggott, Keeley M Fairbrass, Christopher J Black, David J Gracie, Alexander Charles Ford
Novel symptom clusters predict disease impact and healthcare utilisation in inflammatory bowel disease: Prospective longitudinal follow-up study. Alimentary pharmacology & therapeutics (2023)
Keeley M Fairbrass, Jessica Lovatt, Brigida Barberio, Yuhong Yuan, David J Gracie, Alexander Charles Ford
Bidirectional brain-gut axis effects influence mood and prognosis in IBD: a systematic review and meta-analysis. Gut (2021)
Keeley M Fairbrass, Deloar Hoshen, David J Gracie, Alexander Charles Ford
Effect of ACE inhibitors and angiotensin II receptor blockers on disease outcomes in inflammatory bowel disease. Gut 70 (1) (2020)
Christopher J Black, Orla Craig, David J Gracie, Alexander Charles Ford
Comparison of the Rome IV criteria with the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care. Gut 70 (6) (2020)
Yannick Derwa, Christopher J M Williams, Ruchit Sood, Saqib Mumtaz, M Hassan Bholah, Christian P Selinger, P John Hamlin, Alexander C Ford, David J Gracie
Factors affecting clinical decision-making in inflammatory bowel disease and the role of point-of-care calprotectin. Therapeutic advances in gastroenterology 11 (2018)
David J Gracie, Y Derwa, P J Hamlin, Alexander Charles Ford
Editorial: probiotics in inflammatory bowel disease-wrong organisms, wrong disease, or flawed concepts? Authors' reply. Alimentary pharmacology & therapeutics 46 (6) (2017)
Y Derwa, David J Gracie, P J Hamlin, Alexander Charles Ford
Systematic review with meta-analysis: the efficacy of probiotics in inflammatory bowel disease. Alimentary pharmacology & therapeutics 46 (4) (2017)
David J Gracie, A C Ford
Letter: causes of fatigue in inflammatory bowel disease remain uncertain. Alimentary pharmacology & therapeutics 45 (5) (2017)
Ruchit Sood, David J Gracie, M J Gold, N To, M I Pinto-Sanchez, P Bercik, P Moayyedi, A C Ford, G R Law
Derivation and validation of a diagnostic test for irritable bowel syndrome using latent class analysis. Alimentary pharmacology & therapeutics 45 (6) (2017)
Ruchit Sood, David J Gracie, M J Gold, N To, M I Pinto-Sanchez, P Bercik, P Moayyedi, Alexander Charles Ford, G R Law
Editorial: latent class analysis to improve confidence in the diagnosis of IBS - authors' reply. Alimentary pharmacology & therapeutics 45 (9) (2017)
David J Gracie, Alexander Charles Ford
Editorial: mesalazine to prevent recurrent acute diverticulitis-the final nail in the coffin. Alimentary pharmacology & therapeutics 46 (4) (2017)

David J Gracie.css-eqlu8i{font-size:small;padding-left:4px;} (D J Gracie)

Publication Activity (10 Years)

Top Topics

Top Venues

David J Gracie (D J Gracie)